Chuikyo Defers Coverage for SaMD for Breast Cancer Recurrence Risk Assessment; Software Remains Incomplete

December 3, 2021
The Central Social Insurance Medical Council (Chuikyo) on December 1 agreed to defer insurance coverage for Exact Sciences’ software as a medical device (SaMD) used to assess the risk of breast cancer recurrence. The company says that program development had...read more